Karyopharm Therapeutics
KPTI
#9773
Rank
S$43.7 M
Marketcap
$5.19
Share price
0.00%
Change (1 day)
183.00%
Change (1 year)

P/S ratio for Karyopharm Therapeutics (KPTI)

P/S ratio as of April 2025 (TTM): 0.2196

According to Karyopharm Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.1715. At the end of 2024 the company had a P/S ratio of 0.6091.

P/S ratio history for Karyopharm Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20240.6091-10.22%
20230.6784-72.32%
20222.455.85%
20212.32-78.04%
202010.5-65.6%
201930.663.1%
201818.8-93.34%
2017282-88.79%
2016> 100032.44%
2015> 1000-64.59%
2014> 1000206.35%
2013> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.20 1,358.18%๐Ÿ‡บ๐Ÿ‡ธ USA
2.33 962.31%๐Ÿ‡บ๐Ÿ‡ธ USA
5.21 2,272.79%๐Ÿ‡บ๐Ÿ‡ธ USA
4.51 1,952.60%๐Ÿ‡บ๐Ÿ‡ธ USA